ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL1789843
CHEMBL1789843
Compound Name BELIMUMAB
ChEMBL Synonyms BENLYSTA | LYMPHOSTAT-B | LYMPHOSTAT-B BENLYSTA | BELIMUMAB
Max Phase 4 (Approved)
Trade Names LYMPHOSTAT-B | BENLYSTA | LYMPHOSTAT-B BENLYSTA

Sources

  • British National Formulary
  • Clinical Candidates
  • Manually Added Drugs
  • USP Dictionary of USAN and International Drug Names
  • WHO Anatomical Therapeutic Chemical Classification

Molecule Features

CHEMBL1789843 compound icon
Drug Type:Antibody Rule of Five:N First In Class:N Chirality:Single Stereoisomer Prodrug:N Oral:N Parenteral:Y Topical:N Black Box:N Availability Type:Prescription-only

Mechanism of Action

Mechanism of Action ChEMBL Target References
Tumor necrosis factor ligand superfamily member 13B inhibitor Tumor necrosis factor ligand superfamily member 13B DailyMed

Indications

MESH Heading MESH ID EFO ID EFO Term Max phase for indication References
Scleroderma, SystemicD012595EFO:0000717systemic scleroderma2ClinicalTrials
Glomerulonephritis, MembranousD015433EFO:0004254membranous glomerulonephritis2ClinicalTrials
Lupus NephritisD008181EFO:0005761lupus nephritis3ClinicalTrials
Arthritis, RheumatoidD001172EFO:0000685rheumatoid arthritis2ClinicalTrials
Sjogren's SyndromeD012859EFO:0000699Sjogren syndrome2ClinicalTrials
Graft vs Host DiseaseD006086EFO:0004599acute graft vs. host disease1ClinicalTrials
Lupus Erythematosus, SystemicD008180EFO:0002690systemic lupus erythematosus4ClinicalTrials
DailyMed
Immune System DiseasesD007154EFO:0000540immune system disease4ATC
Purpura, Thrombocytopenic, IdiopathicD016553EFO:0007160autoimmune thrombocytopenic purpura2ClinicalTrials
MyositisD009220EFO:0000783myositis2ClinicalTrials
VasculitisD014657EFO:0006803vasculitis3ClinicalTrials

Clinical Data

ClinicalTrials.gov BELIMUMAB
The Cochrane Collaboration BELIMUMAB

Compound Cross References

ATC L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 - IMMUNOSUPPRESSANTS
L04A - IMMUNOSUPPRESSANTS
L04AA - Selective immunosuppressants
L04AA26 - belimumab

ChemSpider ChemSpider Identifier not yet assigned
DailyMed belimumab
spacer
spacer